Earnest Partners LLC reduced its stake in Molina Healthcare, Inc. (NYSE:MOH) by 5.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 589,141 shares of the company’s stock after selling 31,137 shares during the period. Earnest Partners LLC owned approximately 0.99% of Molina Healthcare worth $45,175,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in the company. Renaissance Technologies LLC grew its stake in shares of Molina Healthcare by 53.5% in the 4th quarter. Renaissance Technologies LLC now owns 2,156,150 shares of the company’s stock valued at $165,334,000 after purchasing an additional 751,800 shares during the period. Jana Partners LLC grew its stake in shares of Molina Healthcare by 52.5% in the 3rd quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock valued at $146,139,000 after purchasing an additional 731,992 shares during the period. Iridian Asset Management LLC CT bought a new stake in shares of Molina Healthcare in the 4th quarter valued at approximately $128,179,000. Victory Capital Management Inc. grew its stake in shares of Molina Healthcare by 36.0% in the 4th quarter. Victory Capital Management Inc. now owns 1,590,409 shares of the company’s stock valued at $121,953,000 after purchasing an additional 420,756 shares during the period. Finally, Tiedemann Wealth Management LLC grew its stake in shares of Molina Healthcare by 7.8% in the 3rd quarter. Tiedemann Wealth Management LLC now owns 1,440,066 shares of the company’s stock valued at $135,000 after purchasing an additional 103,775 shares during the period. Institutional investors own 96.22% of the company’s stock.
Molina Healthcare, Inc. (NYSE:MOH) opened at $76.14 on Wednesday. The company has a market capitalization of $4,527.90, a price-to-earnings ratio of 25.87, a price-to-earnings-growth ratio of 1.34 and a beta of 1.28. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.35 and a quick ratio of 1.35. Molina Healthcare, Inc. has a 12-month low of $42.56 and a 12-month high of $93.98.
A number of research firms recently commented on MOH. Goldman Sachs Group began coverage on Molina Healthcare in a research report on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 price target on the stock. ValuEngine lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. JPMorgan Chase & Co. decreased their price target on Molina Healthcare from $103.00 to $91.00 and set an “overweight” rating on the stock in a research report on Thursday, February 15th. Zacks Investment Research upgraded Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $88.00 price target on the stock in a research report on Tuesday, January 2nd. Finally, Leerink Swann increased their price target on Molina Healthcare from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 9th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have issued a buy rating to the company’s stock. Molina Healthcare has a consensus rating of “Hold” and a consensus target price of $73.73.
In other Molina Healthcare news, Director John C. Molina sold 5,385 shares of the stock in a transaction on Friday, January 26th. The stock was sold at an average price of $92.88, for a total value of $500,158.80. Following the transaction, the director now directly owns 414,151 shares in the company, valued at approximately $38,466,344.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Terry Bayer sold 2,804 shares of the stock in a transaction on Monday, January 22nd. The shares were sold at an average price of $91.63, for a total value of $256,930.52. Following the completion of the transaction, the chief operating officer now owns 70,092 shares in the company, valued at $6,422,529.96. The disclosure for this sale can be found here. Insiders sold a total of 425,025 shares of company stock worth $35,069,039 over the last quarter. Corporate insiders own 6.20% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Earnest Partners LLC Has $45.18 Million Stake in Molina Healthcare, Inc. (MOH)” was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/03/14/earnest-partners-llc-has-45-18-million-stake-in-molina-healthcare-inc-moh.html.
Molina Healthcare Profile
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.